Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLC-KA Inhibitors

CLC-Ka inhibitors constitute a distinct class of chemical compounds that specifically target and modulate the function of the CLC-Ka ion channels. These ion channels, predominantly expressed in the kidney and inner ear, play a pivotal role in regulating the transmembrane transport of chloride ions. The term "CLC" stands for "chloride channel" and refers to a family of proteins that facilitate the movement of chloride ions across cell membranes. Among the CLC family, CLC-Ka channels are prominently found in the distal tubules of the kidney nephrons and in the stria vascularis of the cochlea. These channels are crucial for maintaining electrolyte balance and regulating the osmotic pressure within cells. CLC-Ka inhibitors operate by binding to specific regions within the CLC-Ka channel's molecular structure. This interaction disrupts the normal ion conduction pathway through the channel, resulting in a reduction of chloride ion transport.

Many inhibitors exert their effects by either physically obstructing the ion permeation pathway or by altering the channel's conformation, rendering it less conducive to ion flow. These inhibitors exhibit varying degrees of selectivity for CLC-Ka channels, and their mechanisms of action are often rooted in electrostatic interactions and steric hindrance. The specificity of these inhibitors for CLC-Ka channels makes them valuable tools in research aimed at elucidating the physiological roles of these channels in chloride homeostasis and cellular function. Researchers have harnessed the potential of CLC-Ka inhibitors to investigate the fundamental physiological functions of these channels in various tissues and systems. By characterizing the effects of these inhibitors, scientists have gained insights into the roles of CLC-Ka channels in renal chloride reabsorption and inner ear function. While these inhibitors hold promise for advancing our understanding of cellular processes. Their unique mechanism of action and selectivity for CLC-Ka channels position them as crucial tools for unraveling the intricate mechanisms of ion transport and cellular signaling that underlie diverse physiological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Benzamil•HCl

161804-20-2sc-201070
50 mg
$195.00
1
(0)

Benzamil is a diuretic and Na+/Ca2+ exchange inhibitor. It blocks the CLC-Ka channel by reducing its ion flux and inhibiting potassium and chloride transport.